Literature DB >> 17713441

Long-term tolerance to kidney allografts in a preclinical canine model.

Christian S Kuhr1, Murad Yunusov, George Sale, Carol Loretz, Rainer Storb.   

Abstract

Durable immune tolerance supporting vascularized allotransplantation offers the possibility of extending graft survival and avoiding harmful complications of chronic immunosuppression. Immune tolerance to renal allografts was induced in a preclinical canine model through engraftment of donor hematopoietic cells using a combination of low-dose total body irradiation and a short course of immunosuppression. Subsequently, donor renal allografts were transplanted accompanied by bilateral native nephrectomies. With 5-year follow up, we found normal renal function in all recipients and no histological evidence of acute or chronic rejection. This tolerance does not extend universally to donor skin grafts, however, with two of four animals rejecting delayed donor skin grafts. Hematopoietic chimerism produces durable and robust immune tolerance to kidney allografts, although incomplete tolerance to donor skin grafting.

Entities:  

Mesh:

Year:  2007        PMID: 17713441     DOI: 10.1097/01.tp.0000270325.84036.52

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  14 in total

Review 1.  Mixed chimerism and split tolerance: mechanisms and clinical correlations.

Authors:  David P Al-Adra; Colin C Anderson
Journal:  Chimerism       Date:  2011 Oct-Dec

Review 2.  Transplantation tolerance through mixed chimerism.

Authors:  Nina Pilat; Thomas Wekerle
Journal:  Nat Rev Nephrol       Date:  2010-08-31       Impact factor: 28.314

3.  Tolerance to vascularized composite allografts in canine mixed hematopoietic chimeras.

Authors:  David W Mathes; Billanna Hwang; Scott S Graves; James Edwards; Jeff Chang; Barry E Storer; Tiffany Butts-Miwongtum; George E Sale; Richard A Nash; Rainer Storb
Journal:  Transplantation       Date:  2011-12-27       Impact factor: 4.939

4.  Long-term Tolerance Toward Haploidentical Vascularized Composite Allograft Transplantation in a Canine Model Using Bone Marrow or Mobilized Stem Cells.

Authors:  Jeff Chang; Scott S Graves; Tiffany Butts-Miwongtum; George E Sale; Rainer Storb; David Woodbridge Mathes
Journal:  Transplantation       Date:  2016-12       Impact factor: 4.939

Review 5.  Gene therapy in large animal models of muscular dystrophy.

Authors:  Zejing Wang; Jeffrey S Chamberlain; Stephen J Tapscott; Rainer Storb
Journal:  ILAR J       Date:  2009

6.  Immunomodulatory effects of mixed hematopoietic chimerism: immune tolerance in canine model of lung transplantation.

Authors:  R A Nash; M Yunosov; K Abrams; B Hwang; C Castilla-Llorente; P Chen; A S Farivar; G E Georges; R C Hackman; W J E Lamm; M Lesnikova; H D Ochs; J Randolph-Habecker; S F Ziegler; R Storb; B Storer; D K Madtes; R Glenny; M S Mulligan
Journal:  Am J Transplant       Date:  2009-05       Impact factor: 8.086

7.  Long-term tolerance to kidney allografts after induced rejection of donor hematopoietic chimerism in a preclinical canine model.

Authors:  Scott S Graves; David W Mathes; George E Georges; Christian S Kuhr; Jeff Chang; Tiffany M Butts; Rainer Storb
Journal:  Transplantation       Date:  2012-09-27       Impact factor: 4.939

8.  Simultaneous transplantation of hematopoietic stem cells and a vascularized composite allograft leads to tolerance.

Authors:  David W Mathes; Jeff Chang; Billanna Hwang; Scott S Graves; Barry E Storer; Tiffany Butts-Miwongtum; George E Sale; Rainer Storb
Journal:  Transplantation       Date:  2014-07-27       Impact factor: 4.939

9.  Induction of Tolerance Towards Solid Organ Allografts Using Hematopoietic Cell Transplantation in Large Animal Models.

Authors:  Scott S Graves; David W Mathes; Rainer Storb
Journal:  OBM Transplant       Date:  2019-08-23

10.  Heart allograft tolerance induced and maintained by vascularized hind-limb transplant in rats.

Authors:  Quan Liu; Yong Wang; Atsunori Nakao; Wensheng Zhang; Vijay Gorantla; Xin Xiao Zheng
Journal:  Clin Dev Immunol       Date:  2013-03-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.